We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

A Study of CG-806 in Patients With Relapsed or Refractory AML or Higher-Risk MDS

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04477291
Recruitment Status : Recruiting
First Posted : July 20, 2020
Last Update Posted : March 8, 2022
Information provided by (Responsible Party):
Aptose Biosciences Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 2022
Estimated Study Completion Date : June 2023